Elevated uric acid is increasingly linked to glaucoma, retinal vascular disease, macular degeneration, and ocular inflammation. Through endothelial dysfunction and oxidative stress, hyperuricemia may impair ocular microcirculation. Evaluating uric acid levels may be an overlooked step in protecting long-term visual and vascular health.

Vitamin D plays a critical role in thyroid health by regulating immune tolerance, gene expression, and thyroid hormone sensitivity. Low vitamin D levels are strongly associated with autoimmune thyroid diseases such as Hashimoto’s thyroiditis and Graves’ disease, as well as persistent hypothyroid symptoms despite “normal” lab values. Optimizing vitamin D supports immune balance, improves thyroid hormone signaling, and may reduce autoimmune activity.

Atherogenic dyslipidemia—marked by high triglycerides, low HDL, and small dense LDL—often hides behind normal LDL cholesterol. This insulin-resistant lipid pattern predicts cardiovascular disease earlier and more accurately than LDL alone.

Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly called fatty liver, is not a liver problem alone—it is a systemic marker of insulin resistance. Often silent for years, MASLD signals elevated cardiometabolic, cognitive, and longevity risk long before abnormal liver enzymes or diabetes appear.

Hyperinsulinemia often precedes diabetes by decades, quietly driving heart disease, weight gain, hypertension, fatty liver disease, and accelerated aging—even when glucose levels appear normal. Early detection shifts care from reactive treatment to true prevention.

Many patients experience fatigue, weight gain, cold intolerance, and brain fog despite being told their thyroid tests are “normal.” This article explains why thyroid disease is frequently missed, how temperature, genetics, inflammation, diet, and hormone conversion affect symptoms, and why a normal TSH does not rule out clinically meaningful hypothyroidism. Understanding thyroid function beyond basic labs often leads to answers patients have been seeking for years.

Microplastics and nanoplastics have emerged as a previously unrecognized but increasingly relevant source of chronic environmental exposure. Once thought to be biologically inert, these particles—derived from degraded consumer plastics and industrial materials—are now routinely detected in human blood, stool, lung tissue, placenta, breast milk, and even atherosclerotic plaques. Their presence in these tissues challenges long-standing assumptions about plastic safety and raise

Persistent fatigue is not a diagnosis but a signal of underlying physiologic imbalance. Chronic low energy is often driven by overlooked metabolic dysfunction, hormone signaling abnormalities, sleep disruption, immune activation, or autonomic imbalance—frequently despite “normal” labs. A systematic, physician-led evaluation can uncover reversible causes and restore vitality rather than merely suppress symptoms.

Is It Dementia — or Is It Something Else? Cognitive decline is frequently assumed to represent dementia, yet a wide range of medical conditions can closely mimic neurodegenerative disease and are often treatable when identified early. Acute delirium, commonly triggered by infection, dehydration, metabolic abnormalities, or medication effects, is one of the most frequently missed causes of sudden confusion and cognitive change. Medications themselves, particularly anticholiner

Elevated uric acid is more than a marker for gout. Growing evidence suggests it reflects metabolic inflammation and oxidative stress linked to increased colorectal cancer risk. This physician-led review explores how uric acid functions as a predictive biomarker, its relationship to insulin resistance and chronic inflammation, and how average-risk screening tools like Cologuard fit into a modern preventive care strategy focused on early detection and risk reduction.